TFM
NEO icon

TFC Financial Management’s NeoGenomics NEO Stock Holding History

TFC Financial Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-51
Closed -$2K – 560
2021
Q4 		$2K Hold
51
– – ﹤0.01% 478
2021
Q3 		$2K Sell
51
-47
-48% -$2.18K ﹤0.01% 467
2021
Q2 		$4K Hold
98
– – ﹤0.01% 389
2021
Q1 		$5K Hold
98
– – ﹤0.01% 365
2020
Q4 		$5K Buy
+98
New +$4.43K ﹤0.01% 364

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

TFC Financial Management's NEO Position: Q1 2022 in Review

TFC Financial Management sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 51 shares — an estimated $2K sold.

TFC Financial Management first reported a position in NEO in Q4 2020 and held it in 5 quarters. The position peaked at $5K in Q1 2021. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • TFC Financial Management reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • TFC Financial Management sold 51 NeoGenomics shares in Q1 2022, an estimated $2K.
  • TFC Financial Management first reported a position in NeoGenomics in Q4 2020 and held it in 5 quarters.
  • TFC Financial Management's NeoGenomics position peaked at $5K in Q1 2021.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on TFC Financial Management's 13F filing for Q1 2022, filed 4 May 2022.